Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Intralymphatic immunotherapy: a breakthrough approach for allergies

Amber Patterson, MD & Kara Wada, MD & Tiffany Owens, MD
Meds
January 28, 2024
Share
Tweet
Share

Are you or a loved one constantly battling the frustrating symptoms of seasonal or year-round allergies? You are not alone; millions around the globe are affected by sneezing, itchy, watery red eyes, stuffy, runny noses, and headaches. Avoidance of triggers and medications may provide temporary relief, but for those seeking a longer-lasting or more natural solution, immunotherapy (IT) can be life-changing. IT provides sustained benefits of decreased symptoms and medication use for years after treatment completion. Additionally, a full course of IT may prevent the development of future allergies and asthma. Despite these compelling benefits, most patients choose to use medications, even though studies have shown superior effects and cost savings from IT.

The reality is that traditional allergy shots (subcutaneous immunotherapy, or SCIT) are not a practical solution for many patients. A course of SCIT requires dozens of office visits (and injections) over 3 to 5 years. Alternatively, sublingual immunotherapy (SLIT) can be administered daily at home. When I first began offering this in my clinical practice around seven years ago, I thought that this would be the perfect fit for patients who lived far from the clinic or had needle phobias. Perhaps it’s not terribly surprising to learn that most people have a really hard time taking a daily allergy treatment. Studies have demonstrated similarly poor long-term adherence for both SCIT and SLIT. For years, allergists have been searching for the holy grail of treatments. Ideally, this option would be quick, easy, relatively painless, low risk, sustainable, and effective. We may finally be on the horizon with intralymphatic immunotherapy (ILIT).

Intralymphatic immunotherapy represents a significant advancement in allergy treatment. Unlike traditional allergy shots given under the skin, ILIT involves injecting small doses of allergens directly into the lymph nodes under ultrasound guidance. This approach aims to retrain the immune system more efficiently, reducing the allergic response in the long term. By targeting the lymph nodes, where a significant part of the immune response is coordinated, ILIT delivers allergens directly to the heart of the immune system. This direct approach leads to a fast and effective desensitization using small doses of the relevant allergens.

One of the most exciting aspects of ILIT is its potential benefits:

  • Less time: ILIT treatment occurs over an 8-week period of time compared to the 3 to 5 years required by traditional allergy shots and drops/tablets.
  • Fewer injections = less pain: ILIT typically involves ~3 injections compared to dozens, making it a much more convenient and an overall less painful option.
  • Cost savings:  ILIT is calculated to have an overall lower cost of care compared to cost estimates for traditional allergy shots and multiple daily medications.
  • Potential for long-term relief: Studies indicate that ILIT offers lasting relief from allergy symptoms similar to SCIT and SLIT.

The initial studies investigating ILIT began nearly 20 years ago in Europe, and since that time, we have seen a slow but growing body of clinical trial data supporting safety, tolerability, and effectiveness. The clinical adoption of ILIT has been slowed due to a number of factors within the insurance-driven U.S. health care system. That said, ILIT is beginning to become available outside research protocols for aeroallergies, including those to trees, grasses, weeds, molds, dust mites, and pets. When it comes to venom and food allergies, ILIT remains a promising treatment modality under investigation. Current studies are exploring its efficacy and safety, and while initial results are encouraging, more extensive clinical trials are needed. The future of ILIT could revolutionize how we approach allergy treatments.

Kara Wada is a board-certified academic adult and pediatric allergy, immunology, and lifestyle medicine physician, Sjogren’s patient, certified life coach, TEDx speaker, and Dr. Midwest 2023. She can be reached at Dr. Kara Wada and on Instagram, YouTube, Facebook, and LinkedIn. She is a national expert, sought-after speaker, advisor, and host of the Becoming Immune Confident Podcast. She is CEO and founder, The Crunchy Allergist and the Demystifying Inflammation Summit, and serves as the director of clinical content for Aila Health.

Amber Patterson and Tiffany Owens are allergy and immunology physicians.

Prev

Empathy: the unexpected gift from abuse

January 28, 2024 Kevin 0
…
Next

Escaping the time warp: my journey after leaving clinical medicine

January 28, 2024 Kevin 1
…

Tagged as: Allergies & Immunology

Post navigation

< Previous Post
Empathy: the unexpected gift from abuse
Next Post >
Escaping the time warp: my journey after leaving clinical medicine

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

More by Amber Patterson, MD & Kara Wada, MD & Tiffany Owens, MD

  • From doctor to patient: my Sjogren’s journey and a challenge to colleagues

    Kara Wada, MD
  • A specialist’s journey in health care advocacy

    Kara Wada, MD
  • Navigating spring allergies in the era of climate change

    Kara Wada, MD

Related Posts

  • When celebrities attack children with food allergies

    Lianne Mandelbaum, PT
  • Approach the gun violence epidemic like we do with coronavirus

    Charles Nozicka, DO
  • How being an immigrant shaped my approach to patient care

    Monia Sigle
  • Change the approach to triage to alleviate ER overcrowding

    Stephen P. Wood, ACNP-BC
  • Preparing for the next pandemic: Why a one-country approach is needed

    Kelli Todd, MPH and Amy Baruch, MD
  • Esketamine is not a breakthrough new drug: Why the nasal spray for depression is old news

    Erik Messamore, MD, PhD

More in Meds

  • A world without antidepressants: What could possibly go wrong?

    Tomi Mitchell, MD
  • The truth about GLP-1 medications for weight loss: What every patient should know

    Nisha Kuruvadi, DO
  • The hidden bias in how we treat chronic pain

    Richard A. Lawhern, PhD
  • Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

    Robert Trent
  • The anesthesia spectrum: Guiding patients through comfort options in oral surgery

    Dexter Mattox, MD, DMD
  • Functional precision oncology: a game changer in cancer therapy

    Chris Apfel, MD, PhD, MBA
  • Most Popular

  • Past Week

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The dreaded question: Do you have boys or girls?

      Pamela Adelstein, MD | Physician
    • A world without antidepressants: What could possibly go wrong?

      Tomi Mitchell, MD | Meds
    • Rethinking patient payments: Why billing is the new frontline of patient care [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • The silent crisis hurting pain patients and their doctors

      Kayvan Haddadan, MD | Physician
    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • What happened to real care in health care?

      Christopher H. Foster, PhD, MPA | Policy
    • Are quotas a solution to physician shortages?

      Jacob Murphy | Education
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
  • Recent Posts

    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
    • Why great patient outcomes don’t protect female doctors from burnout [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why ADHD in women is finally getting the attention it deserves

      Arti Lal, MD | Conditions
    • How a $75 million jet brought down America’s boldest doctor

      Arthur Lazarus, MD, MBA | Physician
    • Why ruling out sepsis in emergency departments can be lifesaving

      Claude M. D'Antonio, Jr., MD | Conditions
    • The hidden cost of delaying back surgery

      Gbolahan Okubadejo, MD | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • A faster path to becoming a doctor is possible—here’s how

      Ankit Jain | Education
    • Make cognitive testing as routine as a blood pressure check

      Joshua Baker and James Jackson, PsyD | Conditions
    • The dreaded question: Do you have boys or girls?

      Pamela Adelstein, MD | Physician
    • A world without antidepressants: What could possibly go wrong?

      Tomi Mitchell, MD | Meds
    • Rethinking patient payments: Why billing is the new frontline of patient care [PODCAST]

      The Podcast by KevinMD | Podcast
  • Past 6 Months

    • What’s driving medical students away from primary care?

      ​​Vineeth Amba, MPH, Archita Goyal, and Wayne Altman, MD | Education
    • The silent crisis hurting pain patients and their doctors

      Kayvan Haddadan, MD | Physician
    • Internal Medicine 2025: inspiration at the annual meeting

      American College of Physicians | Physician
    • What happened to real care in health care?

      Christopher H. Foster, PhD, MPA | Policy
    • Are quotas a solution to physician shortages?

      Jacob Murphy | Education
    • The hidden bias in how we treat chronic pain

      Richard A. Lawhern, PhD | Meds
  • Recent Posts

    • The broken health care system doesn’t have to break you

      Jessie Mahoney, MD | Physician
    • Why great patient outcomes don’t protect female doctors from burnout [PODCAST]

      The Podcast by KevinMD | Podcast
    • Why ADHD in women is finally getting the attention it deserves

      Arti Lal, MD | Conditions
    • How a $75 million jet brought down America’s boldest doctor

      Arthur Lazarus, MD, MBA | Physician
    • Why ruling out sepsis in emergency departments can be lifesaving

      Claude M. D'Antonio, Jr., MD | Conditions
    • The hidden cost of delaying back surgery

      Gbolahan Okubadejo, MD | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...